Propolis and Royal Jelly for High Blood Pressure

EFFECTS OF PROPOLIS AND ROYAL JELLY SUPPLEMENTATION ON INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION

Recruiting N/A Interventional Study
Systemic Arterial Hypertension Inflammation
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
48 (estimated)
Sponsor
Universidade Federal Fluminense · Other
Who this trial is looking for

This trial is looking for people with high blood pressure. Participants will take royal jelly and propolis for two months to see how it affects their condition.

Are You a Good Fit for This Trial?
Must not be taking Catabolic drugsAntibioticsAntioxidant vitamin supplementsPrebioticsProbioticsSymbiotics

You may be able to join if

  • I have been diagnosed with stage 1 or 2 hypertension
  • I have been on regular treatment for more than 6 months
  • I have not had any changes in my medication doses in the last three months

You may not be able to join if

  • I have an autoimmune disease or infectious disease
  • I have diabetes
  • I have chronic kidney disease
  • I have liver disease
  • I have cancer
  • I have AIDS
  • I am pregnant
  • I regularly take royal jelly or propolis

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study aims to evaluate the effect of the royal jelly and propolis on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of stage 1 and 2 hypertension * Regular treatment for more than 6 months * There have been no changes in medication doses over the last three months. Exclusion Criteria: * Autoimmune and infectious diseases, diabetes * Chronic kidney disease, liver disease, cancer …
Contacts

Denise Mafra, PhD

+5521985683003

dmafra30@gmail.com

CONTACT